Akari Therapeutics' Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)
Stock Information for Akari Therapeutics Plc
Loading
Please wait while we load your information from QuoteMedia.